Anixa Biosciences Inc   (ANIX)
Other Ticker:  


Anixa Biosciences Inc

ANIX's Financial Statements and Analysis

Anixa Biosciences Inc narrowed III. Quarter net loss per share of $-0.09 compare to net loss per share of $-0.14 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.12 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.09 $  0 Mill
$+0.05     Unch.    

Anixa Biosciences Inc 's Revenue fell by 0 % in III. Quarter (Jul 31 2022) year on year, to $0 million and declined by sequentially.

Anixa Biosciences Inc is Expected to report next financial results on March 10, 2023.

More on ANIX's Income Statement

Anixa Biosciences Inc 's in III. Quarter recorded net loss of $-2.775 million, an improvement compare to net loss of $-4.388 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-3.588 million realized in previous quarter.

More on ANIX's Growth

In III. Quarter company's net cash and cash equivalents decreased by $-3 million

Anixa Biosciences Inc does not pay out common stock dividend.

In trailing twelve-month period Anixa Biosciences Inc payed $ -0.32 cash per share, on a free-cash flow basis .